Direct Plan · Growth · Multi Cap · Scheme code 152310
NAV₹11.9230as on 27 Oct 2026
Fund houseDSP Mutual Fund
CategoryMulti Cap
Plan & optionDirect · Growth
History2.6 years
Returns (%)
1M
3M
6M
1Y
3Y
5Y
7Y
10Y
Launch
This scheme
2.18
6.28
7.87
6.05
—
—
—
—
10.61
Nifty 500 Multicap 50:25:25 benchmark
1.30
5.08
5.17
7.10
—
—
—
—
1.44
Multi Cap category median
—
—
—
-1.73
13.78
11.61
—
13.23
—
Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
17.1%
0.24
0.36
0.98
0.33%
-21.3%
93.76
Nifty 500 Multicap 50:25:25 benchmark
17.4%
-0.29
-0.39
—
—
-20.0%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
24 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
390
-5.5%
3.6%
16.1%
20%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
How it behaves against its benchmark
Up capture
Down capture
Correlation
Tracking error
Information ratio
Treynor
101%
98%
0.97
4.4%
0.10
-5.36
Up capture is how much of the benchmark's gain this scheme kept in the months the
benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it
on the up side is the combination every fund is trying for and few reach.
Measured over the 24 months this scheme and
Nifty 500 Multicap 50:25:25 share.
DSP Multi Cap Fund
Direct Plan · Growth
Allocation
By asset
Equity
95.89%
Cash & Equivalents
4.11%
By market cap
Large Cap
102.46%
Mid Cap
88.13%
Small Cap
101.31%
Concentration
Number of stocks
55
Top 5 stocks
22.37%
Top 10 stocks
36.51%
Top 20 stocks
57.81%
Lines in the filing
57
Largest holding
6.40%
Largest sector
Banks 15.56%
Effective stocks
41.8
Sectors held
26
Cash
4.11%
Effective stocks is what the concentration works out to: a fund holding
55 names but most of its money in a few
behaves like a fund of 42. Cash includes repo and TREPS, which
every fund parks money in overnight.
Sector split
Banks
15.56%
Pharmaceuticals & Biotechnology
13.60%
Industrial Products
10.28%
Insurance
8.94%
Automobiles
5.38%
Capital Markets
4.58%
Cash & Equivalents
4.11%
Chemicals & Petrochemicals
3.95%
Consumer Durables
3.89%
Auto Components
3.08%
Retailing
2.96%
IT - Software
2.87%
Healthcare Services
2.44%
Other Consumer Services
2.09%
Consumable Fuels
2.00%
IT - Services
1.89%
Petroleum Products
1.64%
Food Products
1.62%
Aerospace & Defense
1.31%
Electrical Equipment
1.19%
DSP Multi Cap Fund
Direct Plan · Growth · holdings
Top 30 holdings
#
Company
Sector
Shares held
Value ₹ cr
% of fund
1
HDFC Bank Limited
Banks
2,599,587
184
6.40%
2
ICICI Bank Limited
Banks
1,171,751
155
5.38%
3
TREPS / Reverse Repo Investments
Unclassified
—
123
4.27%
4
Axis Bank Limited
Banks
887,126
109
3.78%
5
Max Financial Services Limited
Insurance
743,804
102
3.55%
6
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
181,938
94
3.26%
7
Info Edge (India) Limited
Retailing
697,488
85
2.96%
8
Coforge Limited
IT - Software
473,073
83
2.87%
9
Kirloskar Oil Engines Limited
Industrial Products
353,971
82
2.83%
10
Mahindra & Mahindra Limited
Automobiles
269,334
79
2.76%
11
Cipla Limited
Pharmaceuticals & Biotechnology
582,404
78
2.72%
12
Hero MotoCorp Limited
Automobiles
143,618
75
2.62%
13
APL Apollo Tubes Limited
Industrial Products
319,961
70
2.43%
14
ICICI Lombard General Insurance Co Limited
Insurance
440,726
70
2.43%
15
Gland Pharma Limited
Pharmaceuticals & Biotechnology
223,615
65
2.25%
16
Physicswallah Limited
Other Consumer Services
4,874,915
60
2.09%
17
Coal India Limited
Consumable Fuels
1,355,787
58
2.00%
18
ICICI Prudential Life Insurance Co Limited
Insurance
1,267,753
56
1.95%
19
KEI Industries Limited
Industrial Products
124,782
56
1.93%
20
HDFC Asset Management Co Limited
Capital Markets
233,913
53
1.85%
21
UTI Asset Management Co Limited
Capital Markets
572,387
51
1.75%
22
IPCA Laboratories Limited
Pharmaceuticals & Biotechnology
250,178
48
1.67%
23
Bharat Petroleum Corporation Limited
Petroleum Products
1,559,327
47
1.64%
24
Schaeffler India Limited
Auto Components
120,957
47
1.64%
25
Sai Life Sciences Limited
Pharmaceuticals & Biotechnology
296,086
45
1.57%
26
Sudarshan Chemical Industries Limited
Chemicals & Petrochemicals
370,869
45
1.55%
27
Cyient Limited
IT - Services
383,383
42
1.47%
28
Tube Investments of India Limited
Auto Components
174,691
41
1.44%
29
Polycab India Limited
Industrial Products
51,139
41
1.43%
30
Archean Chemical Industries Limited
Chemicals & Petrochemicals
831,156
40
1.40%
DSP Multi Cap Fund
Direct Plan · Growth · where the money sits
What the manager did last month
Between the filings of 30 Jun 2026 and 31 Jul 2026.
A position grows because the manager bought or because the price rose; only the share count separates them.
Bought
Sold
New positions
Sold out of
Price move of holdings
₹258 cr
₹15 cr
1
1
+1.25%
Stock
Shares traded
Shares
Price
Value ₹ cr
New position
HDFC Asset Management Co Ltd
233,913
entered
—
61.2
Added to
HDFC Bank Ltd
728,031
+38.9%
-6.2%
54.5
ICICI Bank Ltd
315,679
+36.9%
+4.4%
45.3
Alkem Laboratories Ltd
76,129
+80.8%
+3.3%
43.8
Mahindra & Mahindra Ltd
125,518
+87.3%
+10.7%
42.7
Hindustan Aeronautics Ltd
34,299
+73.9%
+6.1%
15.9
Bharat Petroleum Corporation Ltd
492,484
+46.2%
+5.3%
15.8
Cipla Ltd
106,210
+22.3%
+0.5%
15.7
Max Financial Services Ltd
98,523
+22.6%
-5.4%
14.8
Trimmed
Crompton Greaves Consumer Electricals Ltd
450,037
-58.4%
-5.3%
11.7
Cyient Ltd
32,245
-7.8%
-2.8%
2.7
IFB Industries Ltd
7,199
-5.3%
+2.2%
1.0
Sold out of
R R Kabel Limited
121,201
exited
—
29.0
Not equity
Previous filing
This filing
Change
Cash, repo and TREPS
₹0 cr
₹0 cr
+₹0 cr
The list above is stocks and fund units. Treasury bills, repo and money-market
lines roll over every month by design — they are not decisions, so they are totalled here rather
than listed as activity.
Not investment advice. InvestVerdict is not a SEBI-registered Investment
Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 28 Oct 2026.